★ Sign in to follow
BK

Bo Kruse

Executive
Chief Financial Officer
US·SEC (Form 4)
Y-mAbs Therapeutics, Inc.
Total declarations
29
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (25 ops.)
€5.7M

Latest filing published 31 May 2024 for Y-mAbs Therapeutics, Inc., €53k.

Filing timeline

BuySale
Bo Kruse

Insider track record

Disclosed buys
0
Disclosed sells
25

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Bo Kruse: trading record in brief

Bo Kruse (finance chief) discloses dealings in Y-mAbs Therapeutics, Inc. to SEC (Form 4). In total, 29 filings cover trades dated from 13 May 2020 to 31 May 2024.

On the market, this insider has only sold: 25 sales, €5.7M in total. Outside the open market, there are 2 share grants and 2 option exercises. So far in 2024, the count stands at no purchases and 2 sales.

The latest filing, published on 31 May 2024, reports an open-market sale of €318k in Y-mAbs Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Bo Kruse

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations22 total
  • ◇
    Bo Kruse
    EVP, CFO, SECRY & TREAS.ExecutivesY-mAbs Therapeutics, Inc.
    57,258 USD19SEC
    28,629 shares@ US$2.001.6% of flowCommon StockSEC:0001104659-24-067356:0
  • ◆
    Bo Kruse
    EVP, CFO, SECRY & TREAS.ExecutivesY-mAbs Therapeutics, Inc.
    0SEC
    18,100 shares0Common StockSEC:0001415889-24-001644:0
  • ◆
    Bo Kruse
    EVP, CFO, Secry & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    0SEC
    11,700 shares0Common StockSEC:0001104659-23-005026:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    31,400 USD31SEC
    4,000 shares@ US$7.851.7% of flowCommon StockSEC:0001104659-22-026182:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & TreasExecutivesY-mAbs Therapeutics, Inc.
    31,880 USD31SEC
    4,000 shares@ US$7.971.7% of flowCommon StockSEC:0001104659-22-012870:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    39,360 USD31SEC
    4,000 shares@ US$9.842.1% of flowCommon StockSEC:0001104659-22-007441:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    68,480 USD31SEC
    4,000 shares@ US$17.123.6% of flowCommon StockSEC:0001104659-22-001565:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    65,440 USD31SEC
    4,000 shares@ US$16.363.5% of flowCommon StockSEC:0001104659-21-153184:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    65,400 USD31SEC
    4,000 shares@ US$16.353.5% of flowCommon StockSEC:0001104659-21-147273:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    72,360 USD31SEC
    4,000 shares@ US$18.093.8% of flowCommon StockSEC:0001104659-21-143090:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    110,160 USD32SEC
    4,000 shares@ US$27.545.7% of flowCommon StockSEC:0001104659-21-135122:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    103,760 USD32SEC
    4,000 shares@ US$25.945.3% of flowCommon StockSEC:0001104659-21-130079:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    115,120 USD32SEC
    4,000 shares@ US$28.785.9% of flowCommon StockSEC:0001104659-21-123198:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    123,280 USD32SEC
    4,000 shares@ US$30.826.3% of flowCommon StockSEC:0001104659-21-118852:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    128,120 USD32SEC
    4,000 shares@ US$32.036.5% of flowCommon StockSEC:0001104659-21-113880:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    114,400 USD32SEC
    4,000 shares@ US$28.605.8% of flowCommon StockSEC:0001104659-21-109000:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    134,880 USD32SEC
    4,000 shares@ US$33.726.8% of flowCommon StockSEC:0001104659-21-100844:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    138,000 USD32SEC
    4,000 shares@ US$34.507.0% of flowCommon StockSEC:0001104659-21-095581:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    136,600 USD38SEC
    4,000 shares@ US$34.156.9% of flowCommon StockSEC:0001104659-21-089877:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    144,680 USD38SEC
    4,000 shares@ US$36.177.2% of flowCommon StockSEC:0001104659-21-084646:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    133,920 USD38SEC
    4,000 shares@ US$33.486.6% of flowCommon StockSEC:0001104659-21-077698:0
  • ▼
    Bo Kruse
    EVP, CFO, Secretary & Treas.ExecutivesY-mAbs Therapeutics, Inc.
    142,440 USD32SEC
    4,000 shares@ US$35.617.0% of flowCommon StockSEC:0001104659-21-072451:0

22 of 22 declarations

Related entities

No related entities found.